• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

本月基因:GATA3。

Gene of the month: GATA3.

机构信息

Academic Urology Unit, The University of Sheffield, Sheffield, UK.

Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

出版信息

J Clin Pathol. 2023 Dec;76(12):793-797. doi: 10.1136/jcp-2023-209017. Epub 2023 Sep 19.

DOI:10.1136/jcp-2023-209017
PMID:37726118
Abstract

GATA binding protein 3 (GATA3) is a zinc-finger pioneer transcription factor involved in diverse processes. GATA3 regulates gene expression through binding nucleosomal DNA and facilitating chromatin remodelling. Post-translational modifications modulate its activity. During development, GATA3 plays a key role in cell differentiation. Mutations in are linked to breast and bladder cancer. GATA3 expression is a feature of the luminal subtype of bladder cancer and has implications for immune status and therapeutic response. It also has clinical relevance in squamous cell carcinomas and soft tissue sarcomas. This paper reviews the structure and function of GATA3, its role in cancer and its use and pitfalls as an immunohistochemical marker.

摘要

GATA 结合蛋白 3(GATA3)是一种锌指先锋转录因子,参与多种过程。GATA3 通过结合核小体 DNA 并促进染色质重塑来调节基因表达。翻译后修饰调节其活性。在发育过程中,GATA3 在细胞分化中发挥关键作用。突变与乳腺癌和膀胱癌有关。GATA3 的表达是膀胱癌腔型亚型的一个特征,对免疫状态和治疗反应有影响。它在鳞状细胞癌和软组织肉瘤中也具有临床意义。本文综述了 GATA3 的结构和功能、在癌症中的作用以及作为免疫组织化学标志物的应用和陷阱。

相似文献

1
Gene of the month: GATA3.本月基因:GATA3。
J Clin Pathol. 2023 Dec;76(12):793-797. doi: 10.1136/jcp-2023-209017. Epub 2023 Sep 19.
2
GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.GATA3在晚期乳腺癌中的表达:预后价值及器官特异性复发
Am J Clin Pathol. 2015 Nov;144(5):756-63. doi: 10.1309/AJCP5MMR1FJVVTPK.
3
Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas.免疫组织化学评估 GATA3 在肿瘤和正常组织中的表达:用于乳腺癌和尿路上皮癌的有用免疫标志物。
Am J Clin Pathol. 2012 Jul;138(1):57-64. doi: 10.1309/AJCP5UAFMSA9ZQBZ.
4
Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.GATA3免疫组化表达在尿路上皮癌中的诊断效用
Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):244-250. doi: 10.4103/IJPM.IJPM_228_18.
5
The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas With Variant Morphologic Patterns.GATA3在具有变异形态模式的尿路上皮癌诊断中的应用
Appl Immunohistochem Mol Morphol. 2016 Aug;24(7):509-13. doi: 10.1097/PAI.0000000000000221.
6
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder.GATA3 表达缺失与分期进展相关,但与肌层浸润性膀胱癌的预后无关。
Hum Pathol. 2022 Dec;130:10-17. doi: 10.1016/j.humpath.2022.09.004. Epub 2022 Sep 21.
7
Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.雌激素受体与 GATA3 在膀胱癌中的相关性:临床病理意义的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Oct 8;12:684140. doi: 10.3389/fendo.2021.684140. eCollection 2021.
8
Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas.乳腺、膀胱、妇科生殖道及其他细胞角蛋白 7 阳性癌的半定量 GATA-3 免疫反应性。
Am J Clin Pathol. 2014 Jul;142(1):64-71. doi: 10.1309/AJCP8H2VBDSCIOBF.
9
GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.GATA3 突变定义了一种独特的腔面样乳腺癌亚型,其生存得到改善。
Cancer. 2014 May 1;120(9):1329-37. doi: 10.1002/cncr.28566. Epub 2014 Jan 29.
10
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.GATA3功能的转变以及GATA3突变控制着乳腺癌的进展和临床表现。
Breast Cancer Res. 2014 Nov 20;16(6):464. doi: 10.1186/s13058-014-0464-0.

引用本文的文献

1
Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial.GUSTO临床试验中膀胱癌分子亚型的验证
J Pathol Clin Res. 2024 Mar;10(2):e12363. doi: 10.1002/2056-4538.12363.
2
LncRNA Promotes Bladder Uroepithelial Cancer Progression by Stabilizing DDX5.长链非编码RNA通过稳定DDX5促进膀胱尿路上皮癌进展。
J Cancer. 2025 Jan 1;16(3):835-847. doi: 10.7150/jca.104034. eCollection 2025.
3
Development of a prognostic model for early-stage gastric cancer-related DNA methylation-driven genes and analysis of immune landscape.
早期胃癌相关DNA甲基化驱动基因的预后模型开发及免疫格局分析
Front Mol Biosci. 2024 Oct 30;11:1455890. doi: 10.3389/fmolb.2024.1455890. eCollection 2024.